| Impact of tissue-agnostic approvals for patients with sarcoma RC Pestana, JR Beal, A Parkes, N Hamerschlak, V Subbiah Trends in Cancer 8 (2), 135-144, 2022 | 14 | 2022 |
| Response to abemaciclib and Immunotherapy Rechallenge with nivolumab and ipilimumab in a heavily pretreated TMB-H metastatic squamous cell lung cancer with CDKN2A mutation … D Dias e Silva, GB Borba, JR Beal, G Botrus, A Osawa, SEA Araújo, ... International Journal of Molecular Sciences 24 (4), 4209, 2023 | 4 | 2023 |
| Comparação da densidade mineral óssea de coluna lombar e colo femoral GSB Martins, JR Beal, MC Figueiredo, PR de Leu Sampaio, OS Netto Revista de Medicina e Saúde de Brasília 2 (1), 2013 | 4 | 2013 |
| The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development CB Westphalen, D Martins-Branco, JR Beal, C Cardone, N Coleman, ... Annals of Oncology 35 (11), 936-953, 2024 | 3 | 2024 |
| O nome das ondas do Eletrocardiograma DA Reckziegel, LLL Ferreira, LC de Oliveira Lima, JR Beal, ... Revista de Medicina e Saúde de Brasília 1 (2), 2012 | 3 | 2012 |
| Pseudoprogression with neoadjuvant immunotherapy for cutaneous melanoma D Garcia, JR Beal, DM Alvarez, G Schvartsman Case Reports in Oncology 14 (2), 881-885, 2021 | 2 | 2021 |
| Perspectives on the Therapeutic Benefits of Arginine Supplementation in Cancer Treatment FLR Beal, PR Beal, JR Beal, N Carvalho-Neves, OL Franco, ON Silva Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2019 | 2 | 2019 |
| Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing JPB Cassoli, Í Fernandes, L Carvalho, M Fernandes, AF Centrone, ... Current Issues in Molecular Biology 46 (8), 7976-7985, 2024 | | 2024 |
| Molecular Mechanisms and Potential Predictive Biomarkers in Advanced Non-small Cell Lung Cancer: A Summary of Current and Future Trends I Sforzin, JR Beal, F Moura Archives of Surgery and Clinical Research 8 (1), 039-061, 2024 | | 2024 |
| Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study NM Castro, F Moura, AL Hada, D Garcia, ES Victor, G Schvartsman, ... einstein (São Paulo) 22, eAO0575, 2024 | | 2024 |
| 133P Molecular profile and actionability of sarcomas with next-generation sequencing: Insights from a single institution in Brazil M Zugman, M Fernandes, L de Lima, M Teixeira, T Xavier, I Dias, U Junior, ... ESMO Open 9, 2024 | | 2024 |
| P82. 02 Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study J Beal, D Gomes, P Taranto, L Koch, AC Rezende, M Samano, B Bibas, ... Journal of Thoracic Oncology 16 (3), S651-S652, 2021 | | 2021 |
| Immune and targeted therapy for cancer: time to rethink restrictions for the treatment of the elderly and frail JR Beal, G Schvartsman, RR Munhoz, T Karnakis, RA Kaliks Brazilian Journal of Oncology 17 (continuous publication), 2021 | | 2021 |
| Série de Casos de Pacientes com Diagnóstico Ecocardiográfico de Valva Aórtica Quadricúspide WC Cunha, JR Beal, SMF Fontenele, AAK Rabelo, PA Galdeano, ... ABC., imagem cardiovasc, 47-51, 2019 | | 2019 |
| Case Series of Patients with Echocardiographic Diagnosis of Quadricuspid Aortic Valve WC Cunha, JR Beal, SMF Fontenele, AAK Rabelo, PA Galdeano, ... | | 2018 |
